Drug intelligence / Profile preview

Retaine Omega

Development stage
Unknown
Lead developer
OCuSOFT
Modality
Small Molecules
Administration
Oral
01

Overview

Retaine Omega (marketed as Retaine OM3) is an oral dietary supplement developed by OCuSOFT Inc. (CYNACON/OCuSOFT) for the maintenance of ocular surface health and as an adjunct therapy for dry eye management. The formulation features a high-potency blend of omega-3 fatty acids, providing 800mg of eicosapentaenoic acid (EPA) and 400mg of docosahexaenoic acid (DHA) per serving, totaling 1300mg of omega-3 fish oil. It also contains 300mg of omega-6 fatty acids from evening primrose oil and 40mg of bilberry extract. These ingredients work through anti-inflammatory pathways to support tear film stability, reduce ocular surface inflammation, and promote overall eye health. As a dietary supplement, it is classified as a nutraceutical rather than a pharmaceutical drug and is administered as oral softgel capsules.

Brand names
Retaine OmegaRetaine OM3
Other names
Retaine Omega supplements

Beyond the preview

Go deeper on Retaine Omega.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retaine Omega.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call